Cancer Center Clínica Universidad de Navarra (CCUN)
Centro clínico de la Universidad de Navarra
Humboldt University of Berlin
Berlín, AlemaniaPublikationen in Zusammenarbeit mit Forschern von Humboldt University of Berlin (12)
2024
-
Efficacy and safety of niraparib in patients aged 65 years and older with advanced ovarian cancer: Results from the PRIMA/ENGOT-OV26/GOG-3012 trial
Gynecologic Oncology, Vol. 187, pp. 128-138
-
Health-related quality of life in patients with newly diagnosed advanced ovarian cancer treated with niraparib vs placebo: Results from the phase 3 randomized PRIMA/ENGOT-OV26/GOG-3012 trial
Gynecologic Oncology, Vol. 184, pp. 168-177
2023
-
Impact of body composition in advanced hepatocellular carcinoma: A subanalysis of the SORAMIC trial
HEPATOLOGY COMMUNICATIONS, Vol. 7, Núm. 6
-
Robotic versus laparoscopic liver resection for huge (â¥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases
HEPATOBILIARY SURGERY AND NUTRITION, Vol. 12, Núm. 2, pp. 205-216
-
Robotic versus laparoscopic liver resection for huge (â¥10 cm) liver tumors: an international multicenter propensity-score matched cohort study of 799 cases
HEPATOBILIARY SURGERY AND NUTRITION, Vol. 12, Núm. 2, pp. 205-216
2022
-
Addition of Y-90 radioembolization increases tumor response and local disease control in hepatocellular carcinoma patients receiving sorafenib
European Journal of Nuclear Medicine and Molecular Imaging, Vol. 49, Núm. 13, pp. 4716-4726
-
C/EBPβ regulates lipid metabolism and Pparg isoform 2 expression in alveolar macrophages
Science Immunology, Vol. 7, Núm. 75
-
European Association of Cardiothoracic Anesthesiology and Intensive Care (EACTAIC) Fellowship Curriculum: Second Edition
Journal of Cardiothoracic and Vascular Anesthesia, Vol. 36, Núm. 9, pp. 3483-3500
2013
-
Identification of Targets of CD8+ T Cell Responses to Malaria Liver Stages by Genome-wide Epitope Profiling
PLoS Pathogens, Vol. 9, Núm. 5
2009
-
International myeloma working group (IMWG) consensus statement and guidelines regarding the current status of stem cell collection and high-dose therapy for multiple myeloma and the role of plerixafor (AMD 3100)
Leukemia, Vol. 23, Núm. 10, pp. 1904-1912
-
Mobilization in myeloma revisited: IMWG consensus perspectives on stem cell collection following initial therapy with thalidomide-, lenalidomide-, or bortezomib-containing regimens
Blood, Vol. 114, Núm. 9, pp. 1729-1735